TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Duocort Pharma AB
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 1,340 | 1,690 | 1,610 |
Financial expenses | 1 | 64 | 0 |
Earnings before taxes | 8,145 | 997 | 954 |
EBITDA | 8,732 | 1,865 | 1,728 |
Total assets | 17,497 | 9,529 | 8,870 |
Current assets | 17,497 | 8,926 | 7,516 |
Current liabilities | 1,743 | 66 | 661 |
Equity capital | 15,755 | 9,463 | 8,208 |
- share capital | 10 | 10 | 10 |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 90.0% | 99.3% | 92.5% |
Turnover per employee | |||
Profit as a percentage of turnover | 607.8% | 59.0% | 59.3% |
Return on assets (ROA) | 46.6% | 11.1% | 10.8% |
Current ratio | 1003.8% | 13524.2% | 1137.1% |
Return on equity (ROE) | 51.7% | 10.5% | 11.6% |
Change turnover | -319 | 17 | -56 |
Change turnover % | -19% | 1% | -3% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.